ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.

Morgan E Rook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.